Zaynich could play a key role in treating patients suffering from complicated urinary tract infections caused by ...

WOCKHARDT LTD. - Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited ...

Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...

What drove Wockhardt share price today? Wockhardt share price jumped in a weak market after it announced through an exchange filing that a life-saving antibiotic developed by it achieves over 97 ...

Wockhardt share price jumped as much as 4 per cent in early trade on Monday, January 13, defying weak market sentiment. Wockhardt shares opened at ₹1,375.05 against their previous close of ...

The Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf (nafithromycin) as a new treatment for the Community-Acquired Bacterial Pneumonia (CABP) in Adults ...

Testing new antibiotics in India, South Africa, or Brazil, where they are needed most, makes scientific sense. But it’s not without challenges. If the drugs lack global viability, they are less likely ...

N.M. Virani Wockhardt Hospitals Launches URJA a Cutting-Edge LINAC Technology for Advanced Cancer Treatment in Saurashtra ...

Wockhardt's Zaynich, an investigational antibiotic, has been under evaluation for its efficacy in treating complicated ...